Monitoring Patients on IBD Therapies: How to Monitor? What Is the Im…

Cedars Sinai

C. Ha

Top Ten Advances in IBD 2023

Northwestern Medicine Gastroenterology

S. Hanauer

Positioning Medical Therapy in IBD

Washington University in St. Louis

M. Ciorba

DDW 2023 Updates and Perspectives: Evolution in Medical Treatments f…

DDW 2023 Conference Coverage

S. Hanauer

IL12/23 and IL23 Selective Inhibition in Inflammatory Bowel Disease

Gil Melmed

How I Optimize Biologic Therapies in IBD

Providence Swedish

T. L. Zisman

New and Emerging Therapies for Inflammatory Bowel Disease

University of Colorado Department of Medicine

W. Ahmed

Leukocyte Trafficking Agents in the Management of IBD

Washington University in St. Louis

K. Huff-Hardy

Rethinking Current and Future Treatment Sequence of Moderate to Seve…

Columbia University

E. Scherl

Starting IBD Patients on Biologic Therapy: How Long to Wait Before D…

Neeraj Narula

Biosimilar Medications in Rheumatology: Update

Keck School of Medicine of USC

J. Cho

Update of Anti-Integrin Therapy in IBD

Columbia University

B. Sands

Medical Therapy in IBD: Past, Present, and Future

David Choi

Hot Off the Press: What Are We Currently Using? Novel Approved IBD T…

Cedars Sinai

R. Ungaro

Update of Oral Small Molecules in IBD

Columbia University

U. Navaneethan

Anti-Interleukin Therapy in IBD

Washington University in St. Louis

A. Gremida

Managing Fertility, Pregnancy and Nursing in IBD

Scripps Health: 2019 Inflammatory Bowel Disease

U. Mahadevan

Medical Therapy of IBD with Anti-TNF in Pediatric Patients

Columbia University

J. Picoraro

DDW 2023 Updates and Perspectives in IBD

Northwestern Medicine Gastroenterology

S. Hanauer

Biologics – What Do Surgeons Need to Know About Them?

Orlando Colorectal Congress